PropertyValue
?:abstract
  • This issue of the Biomedical Journal acquaints us with the compelling hypothesis that the vascular glycocalyx lies at the intersection of severe COVID-19 risk factors and damages, and the ways used by artificial intelligence to predict interactions between SARS-CoV-2 and human proteins. Furthermore, we explore the antiviral potential of valinomycin and the long list of COVID-19-related clinical trials, and learn how (not) to fix a broken femoral head. Last but not least, we get to enjoy the tale of the cellular oxygen-sensing system as well as the role of the host complement system during Leptospira infection, and learn that SARS-CoV-2 can sometimes come with a pathogenic plus one.
is ?:annotates of
?:creator
?:journal
  • Biomed_J
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Don\'t sugar coat the COVID (only the vasculature)
?:type
?:who_covidence_id
  • #893637
?:year
  • 2020

Metadata

Anon_0  
expand all